| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/27/2001 | WO2001070330A2 Non-invasive body fluid sampling and analysis |
| 09/27/2001 | WO2001070267A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 09/27/2001 | WO2001070260A1 Cd18-binding antibodies inhibit stenosis-related disorders |
| 09/27/2001 | WO2001070002A2 Signal recording of a receptor-effector-system by an extracellular planar potential-sensitive electrode |
| 09/27/2001 | WO2001035097A9 Methods for the quantitation of oxidized glutathione |
| 09/27/2001 | WO2001020294A3 Method and device for the quantitative gas analysis |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001018546A3 Screening for inhibitors of 'paired helical filaments' |
| 09/27/2001 | WO2001018539A3 Mixing chamber |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 09/27/2001 | WO2001012840B1 Anti-epha2 antibodies as a cancer diagnostic |
| 09/27/2001 | WO2001011333B1 Apparatus for real-time measurement of cellular response |
| 09/27/2001 | WO2001010903A3 Proteases and protease inhibitors |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2000075657A3 Screening of target-ligand interactions |
| 09/27/2001 | WO2000057837A8 Compositions and methods for effecting the levels of cholesterol |
| 09/27/2001 | WO2000048004A9 High throughput mass spectrometry |
| 09/27/2001 | WO2000026409A9 Amplified array analysis method and system |
| 09/27/2001 | US20010025189 Module for a computer interface |
| 09/27/2001 | US20010025022 Hnovilr |
| 09/27/2001 | US20010024834 Specific binding substances are disposed on a plurality of surfaces provided by substrate and arranged in direction of thickness of substrate |
| 09/27/2001 | US20010024827 Which express a neuron-specific marker and which can give rise to progeny which can differentiate into neuronal cells; for treatment of neuronal disorders |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024806 Removing contaminants from sperm by mixing with a cationic surfactant, staining the sperm, introducing into a flow cell and irradiating, detecting scattered and fluorescent light intensities, specifiying a region of sperm mass and counting |
| 09/27/2001 | US20010024804 Used to cooperate with a biological sensor for analyzing composition and measuring concentration of a test sample according to electric effect resulted from a biochemical reaction |
| 09/27/2001 | US20010024803 Induced aggregation and agglutination of platelets |
| 09/27/2001 | US20010024802 Centrifugal-density based separation of a blood sample; high speed diagnosis |
| 09/27/2001 | US20010024801 Viable, biologically pure exfoliated fecal colonocytes isolated at normal ambient temperature |
| 09/27/2001 | US20010024800 Mixing plasma with platelet containing fluid, collecting transmission spectrum over predetermined wavelength; determining particle size, aggregation state and compatibility; high speed; blood typing |
| 09/27/2001 | US20010024799 An isolated antibody which specifically binds purified early conception factor; determination of conception within 18-24 hours of breeding |
| 09/27/2001 | US20010024797 Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan binding |
| 09/27/2001 | US20010024795 Detecting very low concentration of a molecule by contacting a sample with a multispecific molecule capable of binding the molecule to be detected forming a complex, which is then bound by another molecule linked by a polymer to many signals |
| 09/27/2001 | US20010024792 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 09/27/2001 | US20010024789 Identifying nucleic acid molecules which encode enzymes using nucleic acid-protein fusions |
| 09/27/2001 | US20010024787 Compositions, kits, and methods for hydrodynamic stress-related regulation of gene expression |
| 09/27/2001 | US20010024784 Binding reagents comprising nucleic acid-protein fusions, each having a protein portion that specifically binds to one of the compounds to be detected, and a nucleic acid which encodes the protein portio and a uniquie identification tag |
| 09/27/2001 | US20010024783 By administering a heat and RnaseH resistant antisense agent and detecting the presence in a body fluid sample of a nuclease-resistant heteroduplex of the antisense oligomer and the target RNA; detecting infective agents, pregnancy |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024647 Single chain variable region immunoglobulin (ScFv) fragment antibody that binds selectively to the active conformation of human von Willebrand Factor (vWF) and the antibody inhibits the binding of vWF to platelets |
| 09/27/2001 | US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue |
| 09/27/2001 | US20010023823 NOx gas detecting apparatus |
| 09/27/2001 | DE19853120C1 Transparency, opacity and cloudiness measuring method, uses paper or foil sample fed manually through measuring slit where it is clamped between light source and photodetector |
| 09/27/2001 | DE10024086C1 Phenol-free bacterial stains, useful e.g. for identifying acid-fast mycobacteria, includes e.g. benzyl alcohol as safe alternative for phenol |
| 09/27/2001 | DE10014846A1 Waste water sludge/flocculant condition sensor housing has externally-fitted adjustment control for interior sensor gap |
| 09/27/2001 | DE10014271A1 Enzymatic assay for determining the concentrations of D- and L-lactic acid and acetic acid in sour dough |
| 09/27/2001 | DE10013995A1 Magnetic polyvinyl alcohol carrier material in particle, filter or membrane form for use in isolation of e.g. DNA or in automatic diagnoses is at least partly surface silanized |
| 09/27/2001 | DE10013944A1 Process for the in-situ measurement of aqueous process streams, e.g. beer and milk comprises measuring the alternating current resistance using electrodes, and determining the amount |
| 09/27/2001 | DE10013841A1 Regulating electrical capacity between two electrodes in ionization and/or ozonization device involves controlling effective value of high voltage of high voltage generator |
| 09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |
| 09/27/2001 | DE10012793A1 Sensor for optical detection of analytes, comprises feeding samples containing analyte into separate cavities where they are subjected to an evanescent field produced by total reflection from the sample surface |
| 09/27/2001 | DE10012313A1 Dangerous gases detected by sequentially operated conductivity ring sensors fed by even number of reverse switches |
| 09/27/2001 | DE10011531A1 Raw coke gas sampler feeds analysis instrument via heated electro-filter protected from condensation via a gas cooler |
| 09/27/2001 | DE10011022A1 Apparatus for performing synthesis, analysis or transport processes with a process fluid has a reaction zone with controlled delivery of a process fluid and control fluids with inner analysis and reaction interfaces at the side walls |
| 09/27/2001 | CA2409333A1 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404260A1 Identification of essential genes in prokaryotes |
| 09/27/2001 | CA2404149A1 Prostate cancer markers |
| 09/27/2001 | CA2404139A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2404136A1 Improved interface patch clamping |
| 09/27/2001 | CA2404039A1 One-dimensional arrays on optical fibers |
| 09/27/2001 | CA2404009A1 Magnetic, silanised polyvinylalcohol-based carrier materials |
| 09/27/2001 | CA2403803A1 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid |
| 09/27/2001 | CA2403788A1 Receptor-binding compounds and methods for identifying them |
| 09/27/2001 | CA2403784A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2403760A1 Detection of immunological memory, t-cell conjugates for pathology imaging and therapy |
| 09/27/2001 | CA2403708A1 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
| 09/27/2001 | CA2403669A1 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | CA2403579A1 Electrochemical biosensor test strip with recognition electrode and readout meter using this test strip |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403556A1 A systematic approach to the analysis of gene function |
| 09/27/2001 | CA2403549A1 Method for detecting an analyte by fluorescence |
| 09/27/2001 | CA2403481A1 Electrochemical biosensor readout meter |
| 09/27/2001 | CA2403444A1 Restenosis treatment |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2403427A1 Method and apparatus for assay for multiple analytes |
| 09/27/2001 | CA2403359A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 09/27/2001 | CA2403090A1 Whole-body optical imaging of gene expression and uses thereof |
| 09/27/2001 | CA2402834A1 Brca-1 regulators and methods of use |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402737A1 Cell patterning technique |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402285A1 Nimr compositions and their methods of use |
| 09/27/2001 | CA2402271A1 Combined polynucleotide sequences as discrete assay endpoints |
| 09/27/2001 | CA2402263A1 Polymer coated surfaces for microarray applications |
| 09/27/2001 | CA2401067A1 Methods for screening and identifying pathogen virulence factors |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2398725A1 Apparatus and method for electrophysiological testing |
| 09/27/2001 | CA2383848A1 Diagnosis of a person's risk of developing alcoholism |
| 09/27/2001 | CA2374406A1 Microarray-based analysis of polynucleotide sequence variations |
| 09/27/2001 | CA2374393A1 Methods of detecting polynucleotide kinase and its use as a label |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/27/2001 | CA2302121A1 Liquid metal quality sensors |
| 09/26/2001 | EP1136933A2 Systems and computer software products for gene expression analysis |
| 09/26/2001 | EP1136824A1 Fluid simulating the rheological properties of biological fluids |
| 09/26/2001 | EP1136823A2 Method for identifying and enriching cell specific target structures |
| 09/26/2001 | EP1136822A2 Method for identifying cell specific target structures |
| 09/26/2001 | EP1136811A1 Method and device for measuring internal information of scattering absorber |